Hypertonic dextrose 25% for prolotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hypertonic dextrose 25% for prolotherapy, covering 2025-03-05 to 2025-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Therapeutic Effect of Proliferative Therapy (Prolotherapy) on Pain Using Injectable Hypertonic Dextrose 25% Versus Injectable Dextrose 10% in Retrodiscal Tissues in Patients With Anterior Disc Displacement With Reduction: A Randomized Clinical Trial . [Phase 2, Phase 3]